Vaccines

WASHINGTON — Chinese intelligence hackers were intent on stealing coronavirus vaccine data, so they looked for what they believed would be an easy target. Instead of simply going after pharmaceutical companies, they conducted digital reconnaissance on the University of North Carolina and other schools doing cutting-edge research.

Country / Region Tags:

China

Europe

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about Medical Espionage: Race for Coronavirus Vaccine Pits Spy Against Spy
Log in or register to post comments

Pharma Companies Plan Joint Pledge on Vaccine Safety

Sat, 2020-09-05 09:17 — mike kraft

A group of drug companies competing with one another to be among the first to develop coronavirus vaccines are planning to pledge early next week that they will not release any vaccines that do not follow rigorous efficacy and safety standards, according to representatives of three of the companies.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pharma Companies Plan Joint Pledge on Vaccine Safety
Log in or register to post comments

Delivering super-cooled COVID-19 vaccine a daunting challenge for some countries

Fri, 2020-09-04 17:28 — mike kraft

Delivering super-cooled COVID-19 vaccine a daunting challenge for some countries Getting a coronavirus vaccine from manufacturing sites to parts of the developing world supply will be an immense challenge, given the need to store some vials at temperatures as low as minus 80 Celsius (-112 Fahrenheit), Deutsche Post warned on Tuesday. Matthias Inverardi U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Read more about Delivering super-cooled COVID-19 vaccine a daunting challenge for some countries
Log in or register to post comments

Results of Russia's COVID-19 vaccine produced antibody response: The Lancet

Fri, 2020-09-04 09:59 — mike kraft

Results of Russia's COVID-19 vaccine produced antibody response: The Lancet Russia's "Sputnik-V" COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics. Polina Ivanova U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Results of Russia's COVID-19 vaccine produced antibody response: The Lancet
Log in or register to post comments

Widespread COVID-19 vaccinations not expected until mid-2021, WHO says

Fri, 2020-09-04 09:40 — mike kraft

Widespread COVID-19 vaccinations not expected until mid-2021, WHO says The World Health Organization does not expect widespread vaccinations against COVID-19 until the middle of next year, a spokeswoman said on Friday, stressing the importance of rigorous checks on their effectiveness and safety. Stephanie Nebehay U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Widespread COVID-19 vaccinations not expected until mid-2021, WHO says
Log in or register to post comments

Top Adviser To Operation Warp Speed Calls An October Vaccine 'Extremely Unlikely'

Thu, 2020-09-03 19:26 — mike kraft

The Centers for Disease Control and Prevention is asking states to have a plan in place to distribute a COVID-19 vaccine as soon as late October — but that doesn't mean an effective treatment will be ready quite so soon.

In separate interviews Thursday with NPR, the chief scientific adviser to the Trump administration's vaccine development effort and the former director of the CDC's office of public health preparedness cautioned that an effective vaccine is likely still months away.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Top Adviser To Operation Warp Speed Calls An October Vaccine 'Extremely Unlikely'
Log in or register to post comments

Five Military Sites Chosen for Phase III Trial of COVID Vaccine Candidate

Thu, 2020-09-03 14:20 — mike kraft

Five Military Sites Chosen for Phase III Trial of COVID Vaccine Candidate AstraZeneca is seeking 30,000 volunteers for the trial, which may lead to an effective vaccine by year’s end. Patrick Tucker Defense One

The Defense Department has selected five sites across several states to stage a Phase III clinical trial for one of the leading COVID-19 vaccine contenders.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report